JSI RESOURCES: Publications

Advancing PrEP


Pre-exposure prophylaxis (PrEP) is a critical intervention for HIV prevention: a daily antiretroviral pill, PrEP can reduce HIV acquisition risk by 92% to 99% for HIV-negative individuals when taken correctly.

JSI supports PrEP research and the development of national PrEP policies and service delivery guidance that respect and protect the human rights of all people at risk of acquiring HIV.

Partner with Us

We strive to build lasting relationships to produce better health outcomes for all.